Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Prostate Cancer
Clinical trial register · Italy

Prostate Cancer Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6779 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:19 UTC
6779
Studies in scope
all four open statuses
4070
Recruiting now
open to new participants
1013
Lead sponsors
across recruiting studies
Top sites
Milan 21 Naples 8 Rome 8 Roma 7 Meldola 6
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS San Raffaele5 European Organisation for Research and Treatment of Cancer - EORTC4 Fondazione Policlinico Universitario Agostino Gemelli IRCCS4 Fondazione del Piemonte per l'Oncologia3 Pfizer3 Santa Chiara Hospital2 Astellas Pharma Global Development, Inc.2 Regina Elena Cancer Institute2 AstraZeneca2 University of Milano Bicocca2 Istituto Clinico Humanitas2 University of Alberta1 Bayer1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 UMC Utrecht1 Gustave Roussy, Cancer Campus, Grand Paris1 European Institute of Oncology1 Marco Lorenzo Bonu1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Aristotle University Of Thessaloniki1 University of Turin, Italy1 IRCCS Azienda Ospedaliero-Universitaria di Bologna1 Hospital of Macerata1 Merck Sharp & Dohme LLC1 IRCCS Sacro Cuore Don Calabria di Negrar1 Fundacio Puigvert1 Azienda Ospedaliero-Universitaria Careggi1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 ABX advanced biochemical compounds GmbH1 University of Florence1 Azienda Ospedaliero Universitaria Maggiore della Carita1 Boston Scientific Corporation1 University of Modena and Reggio Emilia1 Niguarda Hospital1 Centro di Riferimento Oncologico - Aviano1 University of Miami1 University Hospital, Ghent1
Site location
Milan21 Naples8 Rome8 Roma7 Meldola6 Florence6 Trento5 Arezzo4 Candiolo4 Padova4 Rozzano4 Bologna4 Negrar3 Cremona3 Orbassano3 Foggia3 Verona3 Brescia2 Modena2 Torino2 Bergamo2 Ravenna2 Monza2 Aviano2 Novara2 Multiple Locations1 Cesena1 Faenza (RA)1 Forlì1 Toscana1 Genova1 Province of Macerata1 Siena1 Terni1 Faenza RA1 Lugo RA1 Meldola (FC)1 Orbassano (TO)1 Bari1 Chieti1 Genoa1 Palermo1 San Giovanni Rotondo1 Carpi1 Parma1 Reggio Emilia1 Turin1 Pavia1
All 48 locations
Target enrolment
to

Prostate Cancer trials in Italy

57 of 6779 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
IRCCS San Raffaele
Observational
376
Milan
2026-11
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
226
Rome
2026-11
Not yet open
Aristotle University Of Thessaloniki
Observational
50
Naples
2026-10-15
Recruiting
Niguarda Hospital
Not applicable
12
Milan
2026-10-01
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
25
Roma, Rome
2026-08-20
Recruiting
Istituto Clinico Humanitas
Observational
20
Rozzano
2026-06-22
Recruiting
University of Turin, Italy
Not applicable
820
Rozzano, Bologna, Florence, Foggia, Genova, Milan, Modena, Naples
2026-03-30
Recruiting
ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
NCT07407608Prostate Cancer, Prostate Cancer (Adenocarcinoma), Prostate Cancer Non-Metastatic
University of Milano Bicocca
Observational
58
Monza
2026-01-28
Recruiting
Nerve-SPARing Robotic Prostatectomy: The Impact of Patient Baseline Profiles on Erectile Function
NCT07747272Prostate Cancer, Prostatectomy, Robotic Surgery, Erectile Function
University of Florence
Observational
300
Florence
2026-01-01
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
100
Aviano
2025-11-19
Recruiting
Pfizer
Phase 3
1,000
Meldola, Ravenna, Rozzano, Orbassano, Rome, Milan, Novara, Padova
2025-09-28
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsPRL-02·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Milan, Roma, Trento
2025-08-19
Recruiting
AstraZeneca
Phase 3
700
Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo
2025-08-06
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
184
Roma
2025-08-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Milan, Rozzano, Rome, Siena, Arezzo, Bergamo, Foggia, Terni
2025-05-13
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
302
Florence, Milan, Negrar, Roma, Torino
2025-04-15
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
806
Foggia, Padova
2025-04-01
By invitation
Prostate Cancer Screening: a Pilot Study
NCT06238661Prostate Cancer
Fondazione del Piemonte per l'Oncologia
Not applicable
4,500
Candiolo
2025-02-17
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
152
Rome
2024-12-20
Recruiting
Azienda Ospedaliero Universitaria Maggiore della Carita
Observational
400
Novara
2024-10-30
Active, closed
Regina Elena Cancer Institute
Not applicable
90
Rome
2024-10-23
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
NCT06866782Prostate Cancer, Advanced Prostate Cancer, Metastatic Prostate Cancer (mPC)
Fundacio Puigvert
Observational
600
Bologna, Florence, Milan
2024-09-17
Recruiting
ABX advanced biochemical compounds GmbH
Phase 3
434
Meldola, Verona
2024-06-13
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,100
Bologna
2024-05-21
Recruiting
Hospital of Macerata
Observational
534
Province of Macerata
2024-01-31
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2
70
Cesena, Meldola
2023-06-27
Recruiting
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
NCT06236373Cancer, Breast Cancer, Prostate Cancer, Thyroid Cancer
University of Modena and Reggio Emilia
Observational
45
Reggio Emilia
2023-04-20
Recruiting
Fondazione del Piemonte per l'Oncologia
Not applicable
36
Candiolo
2023-04-12
Recruiting
IRCCS Sacro Cuore Don Calabria di Negrar
Not applicable
184
Negrar
2023-04-03
Recruiting
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
NCT06292897Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm, Prostatic Neoplasm
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
25
Milan
2023-03-20
Recruiting
Fondazione del Piemonte per l'Oncologia
Observational
400
Candiolo, Orbassano
2023-03-09
Recruiting
European Institute of Oncology
Not applicable
60
Milan
2023-02-20
Recruiting
Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
NCT06783127Prostate Cancer, Castrate Resistant Prostate Cancer, BRCA Mutation
DrugOlaparib
Santa Chiara Hospital
Observational
3,000
Naples, Trento
2023-01-01
Active, closed
University of Alberta
Not applicable
210
Milan
2022-11-30
Recruiting
IRCCS San Raffaele
Observational
2,500
Milan
2022-10-13
Recruiting
IRCCS San Raffaele
Observational
2,500
Milan
2022-02-14
Active, closed
Boston Scientific Corporation
Not applicable
500
Parma, Rome, Verona
2021-12-21
Recruiting
Marco Lorenzo Bonu
Phase 3
310
Brescia
2021-09-30
Active, closed
Pfizer
Phase 3
599
Bologna, Cremona, Meldola, San Giovanni Rotondo, Naples, Aviano, Trento, Arezzo
2021-05-12
Recruiting
University of Milano Bicocca
Observational
30
Monza
2021-04-15
Recruiting
Regina Elena Cancer Institute
Phase 2
146
Rome
2021-02-02
Recruiting
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
NCT05022914Prostate Cancer, Biochemical Relapse Fo Malignant Neoplasm of Prostate, Prostate Adenocarcinoma, Prostate Cancer Recurrent
Azienda Ospedaliero-Universitaria Careggi
Observational
180
Florence
2021-01-19
Active, closed
Istituto Clinico Humanitas
Observational
320
Milan
2021-01-01
Active, closed
AstraZeneca
Phase 1/2
702
Milan, Modena, Naples, Padova, Roma
2020-11-12
Active, closed
Bayer
Observational
805
Multiple Locations
2020-01-30
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,210
Milan
2019-06-06
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT04075305Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer
UMC Utrecht
Observational
8,000
Brescia, Negrar
2019-02-01
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Milan, Naples, Pavia, Verona
2018-04-27
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
61
Torino
2017-12-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Florence, Meldola
2017-09-25
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Recruiting
Santa Chiara Hospital
Observational
3,000
Orbassano, Padova, Trento
2016-12-16
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842Prostate Cancer
DrugsRa223·Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Carpi, Meldola, Milan
2015-10
Recruiting
IRCCS San Raffaele
Observational
20,000
Milan
2015-01-08
Active, closed
Pfizer
Phase 3
1,068
Naples, Roma, Cremona, Faenza RA, Lugo RA, Meldola (FC), Orbassano (TO), Ravenna
2014-12-17
Active, closed
IRCCS San Raffaele
Observational
700
Milan
2014-02
Active, closed
University of Miami
Not applicable
161
Turin
2013-04-04
Rows per page Showing 1–57 of 57
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-italy/condition/prostate-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,779 studies in total at the last sync on 10 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 57 of those studies listing the condition Prostate Cancer.

How many Prostate Cancer trials are recruiting in Italy?

35 of the 57 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:19 UTC sync. A further 5 have not yet opened recruitment, 16 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Prostate Cancer), 57 studies
PhaseStudiesRecruitingShare
Observational252043.9%
Not applicable15626.3%
Phase 310617.5%
Phase 26310.5%
Phase 1/2101.8%

Most active sponsors

Lead sponsors with the most studies (Prostate Cancer)
Lead sponsorStudiesRecruiting
IRCCS San Raffaele53
European Organisation for Research and Treatment of Cancer - EORTC41
Fondazione Policlinico Universitario Agostino Gemelli IRCCS41
Fondazione del Piemonte per l'Oncologia32
Pfizer31
Astellas Pharma Global Development, Inc.21
AstraZeneca21
Istituto Clinico Humanitas21
Regina Elena Cancer Institute21
Santa Chiara Hospital22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.